The GLP-1 Cost Landscape Has Transformed
If you looked at GLP-1 medication pricing a year ago, you saw a market dominated by $1,000+ monthly costs that locked out most people without good insurance. In summer 2026, the picture is radically different. Competition, new formulations, government programs, and direct-to-consumer pricing have created a genuine price war — and patients are the beneficiaries.
Here is every pricing tier available today, who qualifies for what, and how to navigate it with your prescriber.
The Current Pricing Map
| Option | Monthly Cost | Who It's For |
|---|---|---|
| Compounded injectable semaglutide | $99-$179 | Cash-pay patients wanting lowest price, comfortable with injections |
| Wegovy pill (starting dose) | $149 | Cash-pay patients wanting brand-name oral option |
| Orforglipron | ~$149 | Cash-pay patients wanting oral, no food restrictions |
| Wegovy pill (highest dose) | $299 | Cash-pay patients on maintenance oral therapy |
| Brand injectable (with savings card) | $25 | Commercially insured patients with copay cards |
| Medicare GLP-1 Bridge | Copay varies | Medicare Part D beneficiaries (starting July 1, 2026) |
| Brand injectable (list price) | $1,300+ | Uninsured patients without access to alternatives |
How to Find Your Lowest Price
If You Have Commercial Insurance
Check your formulary first. If your plan covers Wegovy or Zepbound, manufacturer savings programs (NovoCare for Wegovy, Lilly programs for Zepbound) can reduce copays to $25/month or less. This is the cheapest option for insured patients — but requires active plan coverage and sometimes prior authorization.
If You Are Uninsured or Your Plan Excludes Weight Loss Medications
The oral options have leveled the playing field. Both Wegovy pill and orforglipron are available at $149/month cash-pay without insurance. Compounded injectable semaglutide from licensed telehealth providers runs $99-$179/month. These are real, sustainable prices — not introductory offers that expire.
If You Are on Medicare
The Medicare GLP-1 Bridge launches July 1, 2026, covering FDA-approved GLP-1 medications through Part D for eligible beneficiaries. This is the first time Medicare has covered anti-obesity medications. Cost-sharing varies by plan but will be significantly below retail pricing. The BALANCE Model extends this into 2027.
If Cost Has Been Your Main Barrier
Additional resources include: NovoCare patient assistance program (for qualifying low-income patients), state pharmaceutical assistance programs, manufacturer savings cards (even without insurance, some programs apply), and nonprofit patient assistance organizations like NeedyMeds and RxAssist.
The Conversation to Have with Your Doctor:
Bring your specific insurance and budget situation to your prescriber. The "best" medication is the one you can afford to take consistently. A $99/month compounded semaglutide that you take every week is clinically superior to a $1,300/month brand-name option you cannot fill.
Compare GLP-1 Providers by Price
Prices vary significantly across telehealth platforms. Compare transparent, all-inclusive pricing from licensed providers.
Compare Providers →$99/mo
$99/mo · LegitScript-certified
From $149/mo
From $149/mo · Licensed pharmacy partner
$179/mo flat
$179/mo flat · No hidden fees
$297/mo
$297/mo · Premium full-service program